Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon

BACKGROUND: Combined pegylated interferon-α and ribavirin therapy has sustained virological response (SVR) rates of 54% to 61%. Pretreatment predictors of SVR to interferon therapy have not been fully investigated yet. The current study assesses a group of chemokines that may predict treatment respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zekri, Abdel-Rahman N, Bahnassy, Abeer A, Mohamed, Waleed S, Alam EL-Din, Hanaa M, Shousha, Hend I, Zayed, Naglaa, Eldahshan, Dina H, Abdel-Aziz, Ashraf Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707769/
https://www.ncbi.nlm.nih.gov/pubmed/23816271
http://dx.doi.org/10.1186/1743-422X-10-218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707769/
https://www.ncbi.nlm.nih.gov/pubmed/23816271
http://dx.doi.org/10.1186/1743-422X-10-218

Ejemplares similares